- Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course. Schöndorf, T., Hoopmann, M., Warm, M., Neumann, R., Thomas, A., Göhring, U.J., Eisberg, C., Mallmann, P. Clin. Chem. (2002)









